Free Trial

Talkspace (TALK) Competitors

Talkspace logo
$2.67 -0.06 (-2.20%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.73 +0.06 (+2.25%)
As of 04/17/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TALK vs. ADUS, ARDT, NHC, PACS, TDOC, AHCO, VRDN, CDNA, AVAH, and PNTG

Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Addus HomeCare (ADUS), Ardent Health Partners (ARDT), National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), Aveanna Healthcare (AVAH), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry.

Talkspace vs.

Addus HomeCare (NASDAQ:ADUS) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Addus HomeCare has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.

Addus HomeCare has higher revenue and earnings than Talkspace. Addus HomeCare is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.15B1.59$62.52M$4.2423.88
Talkspace$187.59M2.40-$19.18M$0.01267.00

Addus HomeCare has a net margin of 6.50% compared to Talkspace's net margin of 0.61%. Addus HomeCare's return on equity of 9.62% beat Talkspace's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.50% 9.62% 7.37%
Talkspace 0.61%0.98%0.84%

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 21.7% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Addus HomeCare received 324 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 68.89% of users gave Addus HomeCare an outperform vote while only 42.86% of users gave Talkspace an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
330
68.89%
Underperform Votes
149
31.11%
TalkspaceOutperform Votes
6
42.86%
Underperform Votes
8
57.14%

In the previous week, Addus HomeCare and Addus HomeCare both had 7 articles in the media. Addus HomeCare's average media sentiment score of 1.06 beat Talkspace's score of 0.94 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Talkspace
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare currently has a consensus target price of $132.78, indicating a potential upside of 31.14%. Talkspace has a consensus target price of $4.50, indicating a potential upside of 68.54%. Given Talkspace's higher possible upside, analysts clearly believe Talkspace is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.00
Talkspace
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Addus HomeCare beats Talkspace on 11 of the 16 factors compared between the two stocks.

Get Talkspace News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TALK vs. The Competition

MetricTalkspaceHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$449.73M$875.02M$5.31B$7.35B
Dividend YieldN/A2.59%5.12%4.30%
P/E Ratio267.2749.7121.8617.80
Price / Sales2.407.23380.5497.75
Price / CashN/A26.1438.2634.64
Price / Book3.764.226.453.98
Net Income-$19.18M-$5.50M$3.22B$247.81M
7 Day Performance-3.96%3.84%2.85%1.80%
1 Month Performance-2.20%1.77%-8.67%-6.97%
1 Year Performance-10.10%74.19%11.46%1.30%

Talkspace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TALK
Talkspace
3.9248 of 5 stars
$2.67
-2.2%
$4.50
+68.5%
-9.2%$449.73M$187.59M267.27500News Coverage
ADUS
Addus HomeCare
4.6411 of 5 stars
$102.17
+1.3%
$132.78
+30.0%
+4.8%$1.86B$1.15B23.3833,200Positive News
ARDT
Ardent Health Partners
N/A$12.52
+6.3%
$20.58
+64.4%
N/A$1.79B$5.97B0.0024,200
NHC
National HealthCare
N/A$92.33
+0.5%
N/AN/A$1.43B$1.30B11.5712,400News Coverage
Positive News
PACS
PACS Group
3.2436 of 5 stars
$9.33
+1.9%
$34.00
+264.4%
-60.5%$1.42B$3.56B0.0032,433
TDOC
Teladoc Health
3.752 of 5 stars
$7.25
flat
$10.94
+50.9%
-48.0%$1.27B$2.57B-1.265,100Upcoming Earnings
Short Interest ↓
Gap Up
AHCO
AdaptHealth
3.6737 of 5 stars
$8.22
-5.1%
$13.80
+67.9%
-17.4%$1.11B$3.26B-4.9810,900
VRDN
Viridian Therapeutics
1.0876 of 5 stars
$13.30
+10.6%
$35.70
+168.4%
-12.9%$1.08B$302,000.00-3.0950News Coverage
Positive News
CDNA
CareDx
3.6697 of 5 stars
$18.90
+0.5%
$31.83
+68.4%
+112.8%$1.05B$333.79M-7.00740Analyst Forecast
Positive News
Gap Up
AVAH
Aveanna Healthcare
0.8907 of 5 stars
$4.71
+4.9%
$5.00
+6.2%
+104.5%$918.89M$2.02B-13.8533,000News Coverage
Gap Up
PNTG
The Pennant Group
3.2813 of 5 stars
$26.03
+2.6%
$34.80
+33.7%
+30.6%$903.81M$695.24M38.285,340Positive News

Related Companies and Tools


This page (NASDAQ:TALK) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners